Deactivation of glutamatergic signaling in the brain is mediated by glutamate uptake into glia and neurons by glutamate transporters. Glutamate transporters are sodium-dependent proteins that putatively rely indirectly on Na,K-ATPases to generate ion gradients that drive transmitter uptake. Based on anatomical colocalization, mutual sodium dependency, and the inhibitory effects of the Na,K-ATPase inhibitor ouabain on glutamate transporter activity, we postulated that glutamate transporters are directly coupled to Na,K-ATPase and that Na,K-ATPase is an essential modulator of glutamate uptake. Na,K-ATPase was purified from rat cerebellum by tandem anion exchange and ouabain affinity chromatography, and the cohort of associated proteins was characterized by mass spectrometry. The ␣1-␣3 subunits of Na,K-ATPase were detected, as were the glutamate transporters GLAST and GLT-1, demonstrating that glutamate transporters copurify with Na,K-ATPases. The link between glutamate transporters and Na,K-ATPase was further established by coimmunoprecipitation and colocalization. Analysis of the regulation of glutamate transporter and Na,K-ATPase activities was assessed using 
Introduction
Within the family of excitatory amino acid transporters (EAATs), the glutamate transporters GLAST (also known as EAAT1) and particularly GLT-1 (also known as EAAT2) are quantitatively the primary players in mediating glutamate uptake in the mammalian CNS (Amara and Fontana, 2002; Shigeri et al., 2004; Kanner, 2006) . Glutamate transporters are sodium-dependent proteins that rely on sodium and potassium gradients generated principally by Na,K-ATPase. Na,K-ATPase, also known as the sodium/ potassium pump, is a ubiquitously expressed membrane-bound enzyme consisting of an ␣ subunit, which contains the binding sites for ATP and the highly potent and selective inhibitor ouabain, and a heavily glycosylated ␤ subunit that is required for full enzymatic activity; the ␤ subunit also functions as an intercellular adhesion protein (Larre et al., 2006; Vagin et al., 2006) .
In addition to the putative indirect reliance on Na,K-ATPase through ion gradients, previous work has hinted at the possibility of a more extensive link between glutamate transporters and Na,K-ATPase. Ouabain has been shown to impair glutamate transporter activity, and injection of ouabain into neonatal rat brain induces excitotoxicity secondary to cellular membrane depolarization (Li and Stys, 2001; Veldhuis et al., 2003) . In the CNS, it has been estimated that at least 40% of the energy delivered by respiration is required by Na,K-ATPase to maintain ion gradients across cell membranes (Astrup et al., 1981) . Thus, it is not surprising that mutations in Na,K-ATPase genes cause a variety of abnormalities in the brain. For example, the loss of one allele through mutations in the ATP1A2 gene that encodes the ␣2 Na,K-ATPase subunit is associated with familial hemiplegic migraine type 2 (De Fusco et al., 2003) , whereas mutations in the ATP1A3 gene coding for ␣3 subunit are associated with rapidonset dystonia parkinsonism (de Carvalho et al., 2004) . Although homozygous ␣2-deficient mice die just after birth, brain tissue from embryonic day 18 ␣2 Ϫ/Ϫ mice showed high expression of c-Fos in the amygdala and piriform cortex before the onset of apoptosis, indicative of neuronal hyperactivity. Of particular note was the observation that reuptake of glutamate and GABA into synaptosomes was impaired in these mice (Ikeda et al., 2003; Kawakami and Ikeda, 2006) . Thus, it is likely that abnormalities in the CNS caused by mutations in Na,K-ATPase genes in mice and humans are attributable, in part, to altered synaptic transmission induced by impaired transmitter reuptake. Finally, the demonstration that cell surface expression and turnover of an AMPA subtype of glutamate receptor is regulated by Na,KATPase activity provides additional evidence linking ATPase complexes to glutamatergic signaling (Zhang et al., 2009 ).
Based on the findings cited above, including the wellestablished sodium dependency of the EAATs and the observa-tion that GLAST and ␣2 Na,K-ATPase are both highly coexpressed in cerebellar Bergmann glia (see below), we hypothesized that Na,K-ATPase and EAATs are physically associated within a single macromolecular complex in the plasma membrane and that Na,K-ATPase is a key regulator of glutamate transporter activity. We tested this hypothesis by chromatographically copurifying the two proteins from rat cerebellum and coimmunoprecipitating the complexes from synaptosomes and transfected human embryonic kidney HEK-293T cells. In addition to colocalization experiments, we also studied the pharmacological properties and functional interactions between glutamate transporters and Na,K-ATPase in rat synaptosomes and cultured astrocytes. Our findings support this hypothesis and imply that the close coupling of the two proteins serves to regulate glutamatemediated neurotransmission.
Materials and Methods

Immunocytochemistry. For immunocytochemistry in adult Sprague
Dawley rats (200 -250 g), the animals were anesthetized by intraperitoneal injection of sodium pentobarbital and perfused transcardially with 0.12 M phosphate buffer, pH 7.4, followed by 4% paraformaldehyde in phosphate buffer. Brains were postfixed in 4% paraformaldehyde for 1 h and cryoprotected by infiltration with 30% sucrose in phosphate at 4°C overnight. After embedding in OCT compound (Sakura Finetek USA), 14-m-thick sagittal sections were cut on a cryostat, mounted on poly-Llysine-coated glass slides, and air-dried overnight at 4°C. The sections were rehydrated in 0.1 M PBS and then incubated in blocking buffer (0.1 M PBS with 5% normal goat serum and containing either 0.2% Tween 20 or 0.2% Triton X-100) for 60 min at 25°C. Primary antibodies were applied to the sections in a humid chamber and incubated overnight at 4°C.
The primary antibodies used were as follows: anti-␣2 Na,K-ATPase (1:200, rabbit polyclonal; Millipore Bioscience Research Reagents), anti-GLAST (1:600, mouse monoclonal; Novocastra Laboratories), anti-GLAST (1:200, rabbit polyclonal; Santa Cruz Biotechnology), anti-␣3 Na,K-ATPase (1:200, clone XVIF9-G10; Novus Biologicals) , anti-GLT-1a (1:500, rabbit polyclonal; Affinity BioReagents), anti-GLT-1b (1:200, mouse monoclonal, clone 10B7; Abcam), and anti-glial fibrillary acidic protein (GFAP) (1:1000, mouse monoclonal, clone GA5; Millipore Bioscience Research Reagents). The secondary antisera used were as follows: goat anti-rabbit AlexaFluor 546 (diluted 1:1000; Invitrogen) or DyLight 594-conjugated AffiniPure goat anti-rabbit IgG (diluted 1:500; Jackson ImmunoResearch) and goat anti-mouse AlexaFluor 488 (diluted 1:000; Invitrogen) or DyLight 488-conjugated AffiniPure goat antimouse IgG (diluted 1:500; Jackson ImmunoResearch). The sections were then washed in PBS, coverslipped with ProLong Gold anti-fade reagent, and visualized using a Zeiss LSM 510 confocal microscope equipped with a 20ϫ lens with a numerical aperture of 0.75 or a 40ϫ oil immersion lens with a numerical aperture of 1.30. Control conditions included omission of primary antibodies.
Membrane preparation and solubilization of proteins from rat cerebellum. All brain membrane preparation and solubilization procedures were performed at 4°C. Four adult rat (Sprague Dawley, 200 -300 g) cerebella were homogenized in 12 ml of buffer (0.32 M sucrose and 4 mM HEPES-NaOH, pH 7.4) on ice, using a glass Teflon homogenizer followed by centrifugation for 20 min at 800 ϫ g. The top two layers were collected and centrifuged for 40 min at 48,000 ϫ g; the supernatant was discarded and the pellet was resuspended in 10 ml 50 mM Tris-HCl, pH 7.4, using a Polytron (setting 6, 6 s). The homogenate was centrifuged at 48,000 ϫ g, the supernatant was discarded, and the pellet was resuspended (using a Polytron) in 5 ml of 50 mM Tris-HCl, pH 7.4. The protein concentration of the suspension was determined using the Quanti-Pro BCA kit (Sigma), and the suspension was centrifuged for 20 min at 48,000 ϫ g. The pellet was resuspended in solubilization buffer (50 mM Tris-HCl, 10% glycerol, 1% Triton X-100, 50 mM NaCl, and 1ϫ Roche protease inhibitor cocktail, pH 7.4) at a protein concentration of 2 mg/ml using a Polytron (setting 6, 4 s). The suspension was incubated on ice with shaking for 1 h, followed by centrifugation for 45 min at 48,000 ϫ g. The supernatant was collected and dialyzed overnight at 4°C in diethylaminoethyl (DEAE) dialysis buffer (50 mM Tris-HCl, 50 mM NaCl, 0.1% glycerol, and 0.1% Triton X-100, pH 8.8).
Anion exchange and ouabain affinity chromatography. All steps were performed at 4°C, and centrifugations were performed at 150 ϫ g (1000 rpm, JA-14 Beckman rotor). DEAE Sepharose Fast Flow anion exchanger (GE Healthcare) was washed and equilibrated in DEAE dialysis buffer at pH 8.8. The solubilized, dialyzed (pH 8.8) sample was added to DEAE Sepharose at a ratio of 1:1 (v/v) and incubated for 1 h, the DEAE beads were washed with 20 bed volumes of dialysis buffer, and fractions were eluted as follows: elution 1 (6 ml, 50 mM Tris-HCl, 50 mM NaCl, 0.1% glycerol, 0.1% Triton X-100, and 1 mM CaCl 2 , pH 7.0) was added to the DEAE beads and incubated for 30 min; the eluant was collected and the beads were subjected to elution 2 using the same buffer as above except the pH was 5.5. The supernatant from the pH 5.5 fraction was collected and dialyzed for 15 h in K ϩ loading buffer (60 mM KCl, 25 mM imidazole, 1 mM EDTA, 1 mM CaCl 2 , and 0.1% Triton X-100, pH 7.4) for subsequent purification on the ouabain affinity matrix.
The ouabain affinity matrix was prepared according to a previously described procedure (Yingst et al., 1998) . One gram g of epoxy-activated agarose (Sigma) with a 12 atom spacer was added to 15 ml of a solution containing 10 or 20 mM ouabain and 100 mM sodium carbonate, pH 8.5, at room temperature. The mixture was then incubated at 37°C for 20 h, after which the beads were washed with 10 ml of 100 mM sodium carbonate buffer, pH 8.5, followed by 10 ml of water. The beads were incubated with 1 M ethanolamine, pH 8.5, for 4 h at 37°C to block unreacted coupling sites. The column was washed with 200 mM Tris-HCl, pH 8.5, and stored in 50 mM imidazole containing NaN 3 , pH 7.4. Before purification, the ouabain affinity column (containing 7.5 ml of beads) was washed with 50 bed volumes of 50 mM imidazole, pH 7.4, and equilibrated with two bed volumes of K ϩ loading buffer. A mock elution was performed with 10 ml of elution buffer (10 mM ouabain, 25 mM imidazole, 150 mM NaCl, and 1ϫ protease inhibitor cocktail, pH 7.4), followed by a wash with 4 bed volumes of K ϩ loading buffer. The DEAE, pH 5.5, eluate (6 ml, dialyzed in K ϩ loading buffer overnight) was incubated with the ouabain affinity matrix for 1 h at 4°C; after 1 h, the column was mounted vertically and drained from the bottom under gravity at 4°C collecting the immediate flow through until there was no buffer left standing above the column (ouabain unretained fraction). The column was then washed at 4°C with 3 bed volumes of K ϩ loading buffer (20 ml). The column was mounted vertically, and the final 1 ml of K ϩ loading buffer was collected (last wash). Elution buffer (5 ml) was then added, the column was rocked at 4°C for 30 min, and the elution buffer was collected (elution fraction 1); three additional elutions of 5 ml each with the same elution buffer were conducted (most of the Na,K-ATPase protein eluted in the first 5 ml fraction). The fractions were analyzed by Western blotting. Elution fraction 1 was also analyzed by mass spectrometry (see below).
Western blotting. Gel electrophoresis was performed on 6 or 10% polyacrylamide gels. After transferring the proteins to nitrocellulose, the blots were incubated in blocking buffer (0.01 M Tris-HCl, 0.15 M NaCl, 0.2% Tween 20, and 5% w/v nonfat dry milk, pH 8.0) overnight at 4°C. The blots were then washed three times with wash buffer (0.01 M Tris-HCl, 0.15 M NaCl, and 0.2% Tween 20, pH 8.0) at room temperature, followed by incubation for 2 h with the primary antibodies as follows: anti-GLAST [1:1000, rabbit polyclonal (Santa Cruz Biotechnology) or 1:500, mouse monoclonal antibody (Novocastra Laboratories)], anti-GLT-1 [1:2000, rabbit polyclonal raised against the sequence N(556)GKSADCSV-EEEPWKREK(573) of rat GLT-1 (Affinity BioReagents)], nonselective anti-␣ Na,K-ATPase (1:2000, mouse monoclonal; Affinity BioReagents), anti-␣1 Na,K-ATPase (6F, 1:500, mouse monoclonal raised against N-terminal amino acids 27-55; University of Iowa, Iowa City, IA), anti-␣2 Na,K-ATPase (1:2000, rabbit polyclonal; Millipore Bioscience Research Reagents), anti-␣3 Na,K-ATPase (1:2000, mouse monoclonal clone XVIF9-G10; Affinity BioReagents), anti-␤2 Na,K-ATPase (1:1000, mouse monoclonal clone 35; BD Biosciences), and anti-c-myc (1:1000, mouse monoclonal clone 9E10 raised against amino acids 408 -437 of the leucine zipper region of human Myc; Millipore). After incubation with primary antibodies, the blots were washed three times in wash buffer, incubated with secondary antibodies including HRP-conjugated goat anti-rabbit IgG antibody (1:30,000; Pierce) or HRP-conjugated donkey anti-mouse IgG (1:2500; Jackson ImmunoResearch) for 2 h, washed three times in wash buffer, followed by detection with ECL Western blotting detection kit (GE Healthcare) or SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific).
Protein identification by mass spectrometry. The eluate obtained after DEAE anion exchange/ouabain affinity purification (ϳ50 g of protein) was precipitated with 25% trichloroacetic acid (final concentration) on ice for 30 min and centrifuged for 30 min at 12,000 ϫ g at 4°C, and the pellet was washed twice with cold acetone (Ϫ20°C) containing 0.05N HCl and centrifuged for 5 min at 12,000 ϫ g at 4°C. The supernatant was removed and the sample was dried at room temperature for 15 min. The proteins were then reduced in 25 mM dithiothreitol, alkylated using 100 mM iodoacetamide, and brought to 1 mM CaCl 2 . The sample was trypsinized by the addition of sequence grade trypsin (1 g; Promega) and incubated at 37°C for 16 h. The digested sample (25 l) was pressure loaded onto a fused silica microcapillary column packed in-house with C-12 reverse-phase Jupiter material (Phenomenex). The peptides were eluted from the HPLC column by progressively increasing the concentration of the organic solvent (95% acetonitrile, 5% H 2 O, and 0.1% trifluoroacetic acid) and then subjected to electrospray ionization and analyzed by an LTQ-XL ion-trap mass spectrometer (Thermo Fisher Scientific). Peptide ions were dynamically selected using data-dependent acquisition by the operating software for fragmentation. The peptide fragmentation spectra were searched against the National Center for Biotechnology Information nonredundant protein database using the SEQUEST computer algorithm on the Sorcerer platform (SageNResearch).
Synaptosome preparation. Synaptosomes were isolated from adult rat forebrain or cerebellum (200 g male Sprague Dawley) according to a previously described protocol (Huttner et al., 1983) . All steps were performed at 4°C. Briefly, one rat forebrain was homogenized in 7 ml of ice-cold buffer (0.32 M sucrose and 4 mM HEPES-NaOH, pH 7.4) using a glass Teflon homogenizer (five to six strokes at 500 rpm). The homogenate was centrifuged for 10 min at 800 ϫ g. The pellet was discarded, and the top two layers were collected and centrifuged for 15 min at 9200 ϫ g. The supernatant was discarded, and the P2 pellet was resuspended in 35 ml of ice-cold buffer and subjected to 15 min centrifugation at 10,200 ϫ g. The resultant pellet (P3, crude synaptosome fraction) was resuspended in 1 ml of buffer, and the protein concentration was measured using the Quanti-Pro BCA kit (Sigma).
Primary cultures of rat astrocytes. Primary cultures of rat astrocytes were prepared as described previously (Ronaldson et al., 2004) . All procedures were performed in accordance with the University of Toronto Animal Care Committee and the Province of Ontario Animals for Research Act. Briefly, neonatal (2 d old) Wistar rats (Charles River Laboratories) were killed by cervical dislocation, and the whole brains were isolated. Cerebral cortices were then dissected and subjected to enzymatic digestion for 30 min in serum-free minimum essential medium containing 2.0 mg/ml porcine pancreatic trypsin (Sigma-Aldrich) and 0.005% DNaseI. The tissue was then mechanically disaggregated to yield a mixed glial cell suspension. Mixed glial cell suspensions were centrifuged (10 min, 100 ϫ g) and resuspended in fresh culture medium consisting of minimum essential medium supplemented with 5% horse serum, 5% fetal bovine serum, and 50 g/ml gentamicin. The cells were incubated in fresh medium at 37°C, 5% CO 2 and 95% air overnight for 10 -12 d, after which they were placed on an orbital shaker at 100 rpm for 2 h to remove contaminating oligodendrocytes, microglia, and neurons. The cultures were grown for an additional 1-3 d (total of 10 -14 d in vitro) before Western blot or D-aspartate uptake analyses.
Rubidium-86 uptake into synaptosomes. Rubidium-86 uptake into synaptosomes to measure the potassium ion pumping activity of Na,KATPase was performed according to a previously described protocol (Fraser and Arieff, 2001) . To preload the synaptosomes with sodium, the pellet was resuspended in 4 ml of preequilibration buffer [in mM: 150 NaCl, 1 MgCl 2 , and 5 3-(N-morpholino)-propanesulfonic acid (MOPS)-Tris, pH 7.4], incubated for 10 min at 37°C, and centrifuged for 5 min at 20,000 ϫ g (Beckman Coulter JA-20 rotor). The synaptosomes were diluted to a protein concentration of 10 mg/ml in preequilibration buffer. To commence uptake, 0.5 Ci of rubidium-86 (PerkinElmer Life and Analytical Sciences) was added to 5 l of 10 mg/ml synaptosome suspension, 10 l of a 10ϫ stock solution of ouabain, and external media (in mM: 140 choline chloride, 5 MgCl 2 , 0.2 EGTA, 1 KCl, and 5 mM MOPS-KOH, pH7.4) to a final volume of 100 l, and the reaction was allowed to proceed for 5 min at 25°C; the reaction was stopped by adding 2 ml of cold 150 mM choline chloride, followed by filtration through Millipore HAWP filters (25 mm, 0.4 M). The filters were washed twice with 2 ml of cold 150 mM choline chloride and counted on a liquid scintillation counter. Controls were performed in the absence of ouabain.
Glutamate transporter assays.
3 H]L-glutamate uptake assays into synaptosomes were performed according to a previously described protocol (Fremeau et al., 2001 ). The crude synaptosomes were diluted to a protein concentration of 0.2 mg/ml in assay buffer (in mM: 10 Tris-acetate, 128 NaCl, 10 D-glucose, 5 KCl, 1.5 NaH 2 PO 4 , 1 MgSO 4 , and 1 CaCl 2 , pH 7.4). A preincubation was performed with or without inhib- Negative controls contained synaptosomes suspended in sodium-free buffer (128 mM choline chloride and 1.5 mM KH 2 PO 4 substituted for 128 mM NaCl and 1.5 mM NaH 2 PO 4 , respectively). All results were adjusted for background by subtracting counts obtained from samples excluding protein (synaptosomes) from the assay.
For experiments in cultured astrocytes, the cells were washed once with assay buffer (in mM: 138 NaCl, 11 D-glucose, 5.3 KCl, 0.4 KH 2 PO 4 , 0.3 Na 2 HPO 4 , 0.7 MgSO 4 , 1.1 CaCl 2 , and 10 HEPES-NaOH, pH 7.4) and incubated in assay buffer with or without glutamate transporter inhibitors 200 M TBOA, 200 M DHK, 1 M WAY213613, or 1 M to 1 mM ouabain at 37°C for 5 min. To commence uptake, 1 M [ 3 H]D-aspartate and 49 M unlabeled D-aspartate were then added and incubated for 5 min at 37°C, after which the reaction was stopped by suctioning off the buffer and washing three times with 0.5 ml of ice-cold assay buffer per well. The samples were dissolved in 500 l of 0.4N NaOH and analyzed via liquid scintillation counting. Negative controls were incubated in sodium-free buffer (138 mM choline chloride and 0.3 mM K 2 HPO 4 substituted for 138 mM NaCl and 0.3 mM Na 2 HPO 4 , respectively). All results are expressed as the mean Ϯ SEM of n experiments of the percentage of the sodium-containing control. Statistical analyses were performed using one-way ANOVA, followed by Dunnett's test when comparing test conditions with the positive control or by Bonferroni's test when comparing between conditions.
Immunoprecipitations. For immunoprecipitations with ␣2 and ␣3 and probing for GLT-1, synaptosomes were prepared from rat forebrain or cerebellum as described above and resuspended in solubilization buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM NaH 2 PO 4 ⅐7H 2 O, 1% NP-40, 1 mM CaCl 2 , and 1ϫ Roche protease inhibitor cocktail, pH 7.5) at a concentration of 1 mg/ml total protein. The suspension was then incubated on ice for 1 h, followed by centrifugation for 45 min at 4°C, 48,000 ϫ g. The resulting supernatant (solubilized synaptosome preparation), was used for immunoprecipitation. Protein A-and G-agarose beads (1:1 slurry; Sigma) were washed with PBS and restored as a 50% slurry; to preclear the samples, the solubilized synaptosome samples were added to 15 l of the protein AϩG slurry and incubated for 30 min at 4°C. The samples were then centrifuged at 14,000 ϫ g for 5 min, and the supernatant was transferred to a new microcentrifuge tube with 2 l of anti-␣3 Na,K-ATPase mouse monoclonal antibody (Affinity BioReagents) or 2 l of anti-␣2 Na,K-ATPase rabbit polyclonal antibody (Millipore Bioscience Research Reagents) and incubated for 1 h, rocking, at 4°C. Separately, protein AϩG agarose beads were incubated in 1 mg/ml bovine serum albumin solution for 1 h, washed, and equilibrated in wash buffer (20 mM TrisHCl, 0.1% TX-100, 1% glycerol, 100 mM NaCl, and 1 mM CaCl 2 , pH 7.5) to make a 50% slurry. After incubating for 1 h with the antibody, 50 l of preblocked protein AϩG beads were added to the samples and incubated overnight on a rocker at 4°C. The agarose beads were collected by centrifugation and washed three times in wash buffer, and the beads were resuspended in 40 l of 2ϫ sample buffer (4% SDS, 63 mM Tris, and 10% glycerol) and 100 mM DTT and incubated for 3 min at 100°C to elute immunoprecipitated proteins. The eluates were subjected to SDS-PAGE and Western blotting. For the immunoprecipitation with ␣2 probing for GLAST, the starting material was crude solubilized membranes from rat cerebellum prepared as described above (see Membrane preparation and solubilization of proteins from rat cerebellum) except that the solubilized cerebellum was dialyzed against DEAE dialysis buffer, pH 7.4. The subsequent procedures for immunoprecipitation were performed as described above.
For immunoprecipitations in HEK-293T cells (American Type Culture Collection), the cells were mock transfected or cotransfected with 2.5 g of wild-type rat ␣2 Na,K-ATPase cDNA in the pcDNA3.0 vector (kindly provided by Drs. V. Canfield and R. Levenson, Penn State College, Hershey, PA) (Canfield and Levenson, 1998) plus 1 g of the rat ␤2 cDNA (kindly provided by Dr. P. Martin-Vasallo, Universidad de La Laguna, Tenerife, Spain) and 2.5 g of rat GLAST cDNA in pcDNA3.1A (kindly provided by Dr. M. Robinson, University of Pennsylvania, Philadelphia, PA) (Susarla et al., 2004) in a 10 cm dish using Lipofectamine 2000. Forty eight hours after transfection, the cells were collected, solubilized, and subjected to immunoprecipitation as described above.
Results
Colocalization of glutamate transporters with Na,K-ATPase ␣ subunits in rat brain As a first step toward testing the hypothesis that EAATs and Na,K-ATPases are components of the same protein complexes, we compared the distributions of GLAST and ␣2 Na,K-ATPase mRNAs in mouse brain as reported in the Allen Brain Atlas (http://www.brain-map.org/). In the mouse cerebellum, the two mRNAs displayed a similarly prominent expression pattern that tracked the Purkinje cell layer in the cerebellar cortex ( Fig. 1 H, I ). The Purkinje cell layer contains the cell bodies of Purkinje neurons and the Bergmann glia whose cell bodies are also in and adjacent to this cellular layer.
To investigate whether the ␣2 Na,K-ATPase and GLAST colocalize to the same cells, immunocytochemical analyses were performed on sagittal sections of adult rat cerebellar cortex. ␣2 Na,K-ATPase immunoreactivity was observed in Purkinje cells and showed diffuse staining in the granule layer (Fig. 1 A) . These results are in agreement with a previous study on the distribution of ␣2 Na,K-ATPase in the cerebellum (Peng et al., 1997) . We also observed that ␣2 Na,K-ATPase is present in the Bergmann glial processes and colocalizes with the glial marker GFAP (Fig. 1 B, C) . Using a monoclonal antibody, prominent expression of GLAST was seen in the molecular layer of the cerebellar cortex, including the processes of the Bergmann glia (Fig. 1 E) in which it colocalized with ␣2 Na,K-ATPase (Fig. 1 F) . Immunostaining for GLAST was also observed in the granule cell layer. Glutamate transporter expression in the cerebellum is known to vary among different mammalian species. Unlike other species such as mice (Takayasu et al., 2005; Williams et al., 2005) and primates (Williams et al., 2005) in which GLAST expression is restricted to the Bergmann glia, in the rat cerebellum GLAST protein expression is present not only in the Bergmann glia but also in the granule cell layer (Chaudhry et al., 1995; Williams et al., 2005) . Together, the results depicted in Figure 1 show that GLAST and ␣2 Na,KATPase are coexpressed in the Bergmann glia of the cerebellar cortex.
Colocalization of GLT-1 with ␣2 and ␣3 Na,K-ATPase subunits was examined in the CA1 region of the rat hippocampus. Two different GLT-1 antibodies were used; a mouse monoclonal antibody that recognizes the GLT-1b splice form was paired with the rabbit anti-␣2 Na,K-ATPase antibody, and a rabbit polyclonal antibody that recognizes the GLT-1a splice variant was paired with the anti-␣3 Na,K-ATPase mouse monoclonal antibody (for locations of GLT-1 antibody epitopes, see supplemen- tal Figure S2 , available at www.jneurosci.org as supplemental material). Thus, the combination of anti-GLT1b with ␣3 Na,KATPase was precluded because both were mouse monoclonal antibodies, and, likewise, the combination of GLT-1a with ␣2 Na,K-ATPase was precluded because both were rabbit polyclonals. GLT-1b immunostaining was absent from the pyramidal cell body layer but showed a diffuse "cloudy" staining pattern corresponding to astrocytic processes outside this layer (Fig. 2 B) , as described previously by Reye et al. (2002) . GLT-1b displayed some, albeit limited, colocalization with ␣2 Na,KATPase in presumably astrocytic processes (Fig. 2C) . The pattern of immunostaining for GLT-1a was different from that seen for GLT-1b; GLT-1a showed more widespread labeling of which only a portion colabeled with the astrocytic marker GFAP (Fig. 2G-I ) . GLT-1a colocalized with ␣3 Na,K-ATPase both within and outside of the pyramidal cell layer, and both proteins also showed regions of nonoverlapping expression ( Fig. 2D-F) . Together, these results indicate that, in the hippocampus, GLT-1b showed some limited colocalization with the glial ␣2 Na,K-ATPase subunit and that the more heavily expressed GLT-1a isoform partially colocalizes with the neuronally expressed ␣3 Na,K-ATPase subunit.
Glutamate transporters copurify and coimmunoprecipitate with Na,KATPase in rat brain
We next sought to ascertain whether GLAST and ␣2 Na,K-ATPase copurify in extracts from the cerebellum. Rat cerebellar membranes were solubilized, and the solubilized material was subjected to purification using DEAE anion exchange chromatography. Western blot analysis indicated that both GLAST and Na,K-ATPase ␣ subunits eluted in the pH 5.5 fraction (Fig. 3) . The pH 5.5 fraction was then dialyzed and applied to an ouabain affinity column, the column was washed, and the bound ATPases were eluted with a buffer containing sodium and a high concentration of ouabain. Western blot analysis of the ouabain affinity eluate using an antibody to GLAST and two antibodies to Na,K-ATPase ␣ subunits showed the presence of GLAST and ␣2 Na,K-ATPase. The bands for GLAST and Na,K-ATPase subunits in the unretained fraction from the ouabain column indicated that the capacity of the column may have been exceeded. Mass spectrometry performed on the ouabain-eluted fraction (fraction 1) confirmed the presence of GLAST and ␣2 Na,K-ATPase (n ϭ 3). In addition, GLT-1 and ␣1 and ␣3 Na,K-ATPase subunits were also unequivocally identified by the fragmentation patterns (tandem mass spectrometry of the trypsin-generated peptides) from the mass spectrometer (see supplemental Figs. S1, S2, available at www.jneurosci.org as supplemental material). Copurification of GLAST and ␣ Na,K-ATPase from adult rat cerebellum by tandem DEAE anion exchange and ouabain affinity chromatography. Chromatography fractions were analyzed on Western blots (WB) probed with a nonselective ␣ Na,KATPase (NKA) antibody (left), an ␣2 Na,K-ATPase-specific antibody (middle), and a GLAST antibody (right). A-C, The ␣ subunits of Na,K-ATPase (seen at 100 kDa in A, B) and the monomeric and dimeric forms of GLAST seen at 65 and 130 kDa (C) were detected in the final eluate from the ouabain affinity column (OUA eluate). Sol CB, Crude solubilized cerebellar membranes; OUA UR, unretained fraction from ouabain affinity column.
The results from the mass spectrometry analysis suggested that, in addition to ␣2 Na,K-ATPase and GLAST, other glutamate transporters may be associated with additional ATPase subunits. To examine this further, immunoprecipitations were conducted on solubilized samples of rat forebrain and cerebellum. Western blot analysis of immunoprecipitations performed using ␣2 and ␣3 Na,K-ATPase-specific antibodies showed that both antibodies selectively immunoprecipitated the respective target proteins (Fig. 4 A, B) . In the same samples, GLT-1 coimmunoprecipitated with both ␣2 and ␣3 Na,K-ATPase subunits in the forebrain samples (Fig. 4C) , and GLAST was coimmunoprecipitated with ␣2 Na,K-ATPase in samples from the cerebellum (Fig. 4 D) .
The effects of glutamate transporter inhibitors and ouabain on glutamate transporter and Na,K-ATPase activities in synaptosomes
In light of our results showing copurification and coimmunoprecipitation of glutamate transporters and Na,K-ATPase in rat brain, we examined the effects of ouabain alone and in combination with glutamate transporter inhibitors on glutamate transporter activity in synaptosomes from rat forebrain and cerebellum. Western blot analysis showed high-level expression of GLT-1 and GLAST in forebrain and cerebellar synaptosomes (Fig. 5A) , and all three ␣ subunits of Na,K-ATPase were detected in both synaptosome preparations (Fig. 5B) .
We used both [ 3 H]D-aspartate and [
3 H]L-glutamate uptake to measure glutamate transporter activity in rat brain synaptosomes. Although ␣2 Na,K-ATPase is expressed primarily in glia with relatively little expression in neurons in the adult CNS (Peng et al., 1997; Moseley et al., 2007) , we observed robust inhibition by ouabain of glutamate transporter activity in synaptosomal preparations from forebrain and cerebellum (Fig. 5C,D) . However, the heterogeneous nature of synaptosomal preparations and the fact that they contain glial fragments is well documented (Henn et al., 1976; Kanerva et al., 1978; Nakamura et al., 1993) . Moreover, the predominant transporter activity in similar forebrain preparations has been reported to be "EAAT2 like" (i.e., GLT-1) in its pharmacology (Dowd et al., 1996; Robinson and Dowd, 1997; Gegelashvili and Schousboe, 1998; Koch et al., 1999) . In the glutamate transporter assays, sodium dependency was tested by excluding sodium ions from the uptake assay buffer; this resulted in greatly reduced transport activity in forebrain and cerebellum synaptosomes compared with control conditions conducted in the presence of sodium (Fig. 5C,D) .
In the presence of sodium ions, the nonselective EAAT inhibitor TBOA inhibited D-aspartate uptake by 88.3 Ϯ 1.5% in forebrain synaptosomes and by 63.6 Ϯ 3.5% in cerebellar synaptosomes, whereas 1 mM ouabain inhibited 37.4 Ϯ 1.8 and 34.2 Ϯ 2.0% of [ 3 H]D-aspartate uptake in forebrain and cerebellar synaptosome preparations, respectively (Fig. 5C,D) . Interestingly, in forebrain synaptosomes, the GLT-1-selective inhibitors DHK and WAY213613 inhibited D-aspartate uptake to a level similar to, albeit slightly lower, than that of ouabain (30.0 Ϯ 1.3 and 32 Ϯ 1.4%, respectively) (Fig. 5C ). In the cerebellar synaptosomes (Fig.  5D) , these compounds produced a lower level of inhibition compared with forebrain synaptosomes, consistent with the lower level of expression of GLT-1 in cerebellum compared with forebrain. In both forebrain and cerebellar synaptosomes, when DHK or WAY213613 was added simultaneously with 1 mM ouabain, a small, nonsignificant enhancement of the inhibition of D-aspartate uptake was observed compared with ouabain alone (Fig. 5C,D) . The relatively small effects of DHK and WAY213613 in cerebellar synaptosomes when each was tested alone and the lack of an enhancement when given simultaneously with ouabain indicated that GLAST, which is insensitive to DHK and WAY213613 at the concentrations used, may be the predominant glutamate transporter associated with Na,K-ATPases in the cerebellum. Similar results with ouabain and transporter inhibitors were observed when [ 3 H]L-glutamate was used instead of [ 3 H]Daspartate (Fig. 4C,D, right panels) .
A dose-response analysis of ouabain on inhibition of [ 3 H]Daspartate uptake was conducted on forebrain and cerebellar synaptosomes. In both preparations, ouabain inhibited [ 3 H]Daspartate uptake in a dose-dependent manner (Fig. 5E, right) . Substantial inhibition was seen with 1 M ouabain, especially in forebrain synaptosomes. This low concentration of ouabain selectively inhibits the rat ␣2 and ␣3 ATPase subunits, which are highly sensitive to inhibition by this drug; at concentrations above ϳ50 M, all three ATPase ␣ subunits (␣1-␣3) are inhibited (Hansen, 2003) . The observation that additional inhibition of glutamate transporter activity was seen at higher concentration of ouabain (100 -1000 M) compared with low (1 M) suggests that a subpopulation of glutamate transporters may also be coupled to ␣1 Na,K-ATPase, which, in the rat, is much less sensitive to ouabain (Shull et al., 1986; Crambert et al., 2004) .
A dose-response analysis of ouabain on the ion pumping activity of Na,K-ATPase was performed using radioactive rubidium-86 as a tracer for potassium ions. In forebrain synaptosomes, the ion pumping activity was ϳ100-fold less sensitive to ouabain compared with glutamate transporter activity (Fig. 5E, left) . These findings indicate that glutamate transporters are broadly sensitive to low and high concentrations of ouabain, whereas the ion pumping activity of Na,K-ATPase in synaptosomes is only inhibited by high ouabain concentrations. The latter observation is consistent with a previous report (Brodsky and Guidotti, 1990) demonstrating that 73% of Na,K-ATPase-mediated rubidium uptake in rat synaptosomes displays very low sensitivity to ouabain (mediated by ␣1 Na,K-ATPase), similar to that shown here in Figure 5E . Our observation that low ouabain concentrations inhibited glutamate transporters but not Na,KATPase ion pumping activity might be explained by a higher proportion of glutamate transporters being coupled to the high-affinity ␣2 and ␣3 Na,K-ATPases rather than the low-affinity ␣1 subunit and/or because the rubidium-86 assay measures total potassium flux of which only part of the flux is associated with Na,K-ATPase. Alternatively, there may be a mechanistic dissociation of the two functions such that the ion pumping activity of Na,K-ATPase is not required for the modulation of glutamate transporter function. For example, the differential ouabain sensitivity might be linked to the ouabain-induced, Src-mediated signaling mechanisms of Na,K-ATPase (see Discussion).
The effects of glutamate transporter inhibitors and ouabain on glutamate transporter activity in cultured astrocytes
Glutamate transporter expression and activity was also measured in cultured rat astrocytes prepared from the cerebral cortex of 2-d-old rats. Western blot analysis in which each sample was normalized for protein (10 g protein per lane) showed that, at 10 -14 d in vitro, astrocytes expressed GLAST but little (if any) GLT-1 (Fig. 6A) . The expression of GLAST but not GLT-1 has also been reported in cultures of human fetal astrocytes (Gegelashvili et al., 2007) . The ␣2 Na,K-ATPase subunit was expressed as was a very low level of ␣1 Na,K-ATPase; no ␣3 Na,K-ATPase expression was observed (Fig.  6B ). In the [ 3 H]D-aspartate uptake assay, neither of the GLT-1 selective inhibitors DHK or WAY213613 significantly affected D-aspartate uptake in the cultured astrocytes, and neither drug significantly affected the level of uptake inhibition when added together with ouabain compared with ouabain alone (Fig. 6C ). Ouabain displayed a bimodal effect on glutamate transporter activity. Ouabain concentrations of 50 M and above inhibited uptake whereas, surprisingly, and in contrast to the findings in synaptosomes, 10 M had no effect, whereas 1 M produced a significant stimulation of D-aspartate uptake (39% above control) (Fig. 6C) . These results indicate that cultured rat astrocytes expressing GLAST but not GLT-1 respond differently to ouabain compared with synaptosomes expressing both GLT-1 and GLAST; whereas higher concentrations of ouabain inhibited glutamate transport in both preparations, low concentrations inhibited transport in synaptosomes but stimulated uptake in cultured astrocytes. The observation that low ouabain concentrations inhibited uptake in cerebellar synaptosomes but stimulated uptake in cultured astrocytes might be related to differences in expression of ␣1 and ␣3 Na,K-ATPase, which were present in the both the forebrain and cerebellar synaptosomes but absent from the cultured astrocytes.
Expression and coimmunoprecipitation studies in HEK-293T cells
To determine whether the results obtained in brain synaptosomal preparations and cultured astrocytes could be recapitulated in a simplified cell system, coimmunoprecipitation experiments were conducted in transfected HEK-293T cells. Western blot analysis conducted on mock-transfected HEK-293T cells to characterize the basal endogenous level of expression of GLAST, GLT-1, and ATPase ␣ subunits showed a low level of GLAST but little if any GLT-1; these cells also expressed ␣1 and ␣3 Na,K-ATPase, but the ␣2 Na,K-ATPase subunit was not detected (Fig. 7A , mock-transfected lanes). Coimmunoprecipitation experiments were conducted on HEK-293T cells cotransfected with GLAST, ␣2, and ␤2 Na,K-ATPase subunits. The GLAST antibody immunoprecipitated GLAST and also coimmunoprecipitated ␣2 Na,K-ATPase, and, conversely, an ␣2 Na,K-ATPase-selective antibody immunoprecipitated ␣2 Na,K-ATPase and coimmunoprecipitated GLAST (Fig. 7B ). These results demonstrate that, as observed in rat brain tissue, GLAST and ␣2 Na,K-ATPase are associated with each other in the same molecular complexes in transiently transfected HEK-293T cells.
The effects of protein kinase inhibitors on [ 3 H]D-aspartate uptake in synaptosomes
One potential mechanism accounting for the ouabain-mediated inhibition of glutamate transporters could be through the actions of protein kinases. Na,K-ATPase is known to be part of a complex that includes Src and other proteins associated with cellular signaling, and inhibition of the ATPase by ouabain stimulates Src activity (Tian et al., 2006) . To investigate the possible role of Src and other kinases in ouabain modulation of glutamate transporters, two potent Src inhibitors, PP2 and SU6656, were tested on [ 3 H]D-aspartate uptake into forebrain synaptosomes. PP2 inhibits Src with an IC 50 of 1-5 M and has a Ͼ100-fold selectivity for Src family kinases over other tyrosine kinases, whereas SU6656 is an exceptionally potent inhibitor of Src with an IC 50 of 280 nM (Hanke et al., 1996) . We used concentrations of PP2 (100 nM) and SU6656 (1 M) that were low enough to retain specificity for Src family protein kinases. Both compounds significantly inhibited uptake compared with controls; the level of inhibition was similar to, and not significantly different from, that of ouabain (Fig. 8 A) . The effects of PP2 or SU6656 when combined with ouabain were not significantly different from that of ouabain alone. In contrast to Src inhibitors, inhibitors of PKA (H89), PKC (staurosporine), and phosphatidylinositol 3-kinase (PI3K) (wortmannin) did not significantly inhibit D-aspartate uptake (Fig. 8 B) . These results demonstrate that, in synaptosomes, inhibition of Src, but not PKA, PKC, or PI3K, inhibits glutamate transporter activity to a level that is similar to that of ouabain.
Discussion
The putative mechanism for driving glutamate transporter activity against a large concentration gradient is based on the indirect coupling of glutamate uptake to Na,K-ATPase activity. Na,KATPase generates an inwardly directed electrochemical sodium gradient that is used by the transporters to drive the uphill transport of the neurotransmitters. The stoichiometry of ion transfer during glutamate transporter activity has been determined to be 3Na ϩ :1H ϩ :1K ϩ :glutamate (Kanner, 2006) . Under physiological conditions, the inwardly directed sodium gradient and outwardly directed potassium gradient promote the accumulation of the transmitter in the cell against its concentration gradient; conversely, at elevated external potassium concentrations, the transporters mediate transmitter efflux out of cells. Previous work has shown a tight coupling of glutamate transporters with Na,KATPase activity whereby, during prolonged, elevated extracellular glutamate levels, intracellular sodium is also elevated to a new steady state in which sodium influx via the transporter is precisely matched by extrusion through the pump (Chatton et al., 2000) .
Because glutamate transporters and Na,KATPases both have an absolute requirement for sodium and potassium, the coupled transporter/ATPase protein complexes may be mutually dependent on each other for satisfying their ion requirements. Our findings that glutamate transporters and Na,K-ATPases are physically associated in the same protein complexes indicates a direct rather than indirect relationship between glutamate transporters and Na,K-ATPases.
The present study was prompted in part by the anatomical overlap of glutamate transporters and subunits of Na,KATPase in the CNS. For example, previous work has shown overlapping patterns of immunostaining of ␣2 Na,K-ATPase with GLT-1 and GLAST in the rat cerebral cortex in which ␣2-containing astrocytic processes are primarily associated with axo/ dendritic appositions and asymmetrical (glutamatergic) synaptic junctions but not with symmetric GABAergic junctions (Cholet et al., 2002) . Our immunocytochemical results from the rat cerebellar cortex demonstrate that ␣2 Na,K-ATPase and GLAST are both highly expressed in the processes of the Bergmann glia infiltrating the molecular layer of the cerebellar cortex. At parallel and climbing-fiber synapses on Purkinje neurons, astrocytic Bergmann glial cells envelop individual excitatory contacts and act as physical barriers between neighboring synapses; this arrangement presumably brings glutamate transporters closer to synaptic release sites. Thus, the contribution of glutamate transporters to cerebellar synaptic transmission is probably substantial and, by comparison, more robust than that which is seen in the hippocampus (Tzingounis and Wadiche, 2007) .
In the rat hippocampus in which GLT-1 is highly expressed, the GLT-1b splice variant showed some astrocytic coexpression with ␣2 Na,K-ATPase. More extensive coexpression was observed with the GLT-1a isoform and ␣3 Na,K-ATPase. ␣3 Na,KATPase is thought to be selectively expressed in neurons of the adult brain (Moseley et al., 2007) . Therefore, our observation that GLT-1a is expressed in some of the same cells as the ␣3 subunit provides additional evidence that, in addition to the well established expression in astrocytes, GLT-1a is also expressed in some neurons. Indeed, at least four splice variants of GLT-1 are expressed in rodent brain (Peacey et al., 2009) , and a growing number of reports have demonstrated neuronal expression of GLT-1 (Chen et al., 2004; Bassan et al., 2008; González-González et al., 2008) .
We were surprised that, although high ouabain concentrations inhibited glutamate transport in cultured astrocytes, low concentrations stimulated D-aspartate uptake; a stimulatory effect was never observed in forebrain or cerebellar synaptosomes at any concentration of ouabain. The cultured astrocytes expressed GLAST but not GLT-1, whereas forebrain and cerebellar synaptosomes expressed both glutamate transporters. The stimulatory effect of low ouabain seen in cultured astrocytes, presumably mediated by GLAST, might have been masked by the inhib- (Mock) showing expression of ␣1 and␣3 Na,K-ATPase (100 kDa) and GLAST (monomer at 65 kDa) and the absence of ␣2 Na,K-ATPase and little or no GLT-1. Rat forebrain (FB) membranes were used as positive controls. B, Antibodies selective for ␣2 Na,K-ATPase and GLAST were used to immunoprecipitate the respective proteins from HEK-293T cells cotransfected with GLAST, ␣2, and ␤2 Na,K-ATPase cDNAs. The samples were analyzed by Western blots probed with GLAST (left) and ␣2 Na,K-ATPase-specific (right) antibodies. The ␣2 subunit of Na,K-ATPase (seen at 100 kDa) coimmunoprecipitated using the GLAST antibody, and, conversely, GLAST (dimer seen at 130 kDa) coimmunoprecipitated using the ␣2 Na,K-ATPase-specific antibody. SOL., Crude solubilized HEK-293T cells cotransfected with GLAST, ␣2, and ␤2 Na,K-ATPase; ϪAB, negative control excluding antibody in the immunoprecipitation step.
itory effects on GLT-1 in the synaptosomes. Interestingly, wholecell patch-clamp analysis conducted on isolated guinea pig, canine, and human cardiac myocytes to directly measure the sodium pump current showed that nanomolar concentrations of ouabain and dihydro-ouabain stimulated Na,K-ATPase activity (Gao et al., 2002) . When the contributions of the high ouabain affinity ␣2 (in pig cardiomyocytes) and ␣3 (in canine cardiomyocytes) isoforms could be separated from that of the low-affinity ␣1 isoform, it was only the high-affinity isoforms that were stimulated. These observations prompted Gao et al. (2002) to suggest that this may represent a novel mechanism of isoform-specific regulation of Na,K-ATPase in the heart by nanomolar concentrations of endogenous ouabain-like molecules. Considerable evidence exists for the presence of endogenous ouabain-like molecules or "endobains" in tissues that may serve to regulate Na,KATPase activity (Hamlyn et al., 1991; Goto et al., 1992; Schoner and Scheiner-Bobis, 2007) . Endogenous ouabain molecules may participate in modulating glutamate transporter activity via the high ouabain affinity ␣2 Na,K-ATPase expressed in astrocytes and possibly by the high-affinity ␣3 subunit present in neurons.
Although the focus of our work has been on the regulation of glutamate transporters by Na,K-ATPases, there is also evidence that glutamate transporters can modulate Na,K-ATPases. Gegelashvili et al. (2007) have shown that, in human fetal astrocytes, application of glutamate stimulates increased expression of GLAST and increased activity of Na,K-ATPase. The increased Na,K-ATPase activity was attributable to increased targeting of the ␥ subunit (FXYD2) to the plasma membrane. The FXYD2 protein (␥) subunit is an auxiliary component of some but not all Na,K-ATPase holomeric complexes that appears to modulate the affinity for sodium and potassium. It was concluded that increased activity of GLAST directs FXYD2/␥ to the cell surface and that this in turn leads to the activation of the astroglial sodium pump, presumably attributable to the modulatory effect of the ␥ subunit on the kinetic parameters of the catalytic ␣ subunit of the Na,K-ATPase. Gegelashvili et al. (2007) also suggested that the cytoplasmic domain of the ␥ subunit, which is enriched with basic amino acid residues, might act as an interface for binding directly to the negatively charged amino acids in the extreme C terminus of GLAST.
The involvement of protein kinases in the regulation of glutamate transporters by Na,K-ATPase was also explored. The effects of protein kinases on glutamate transporters are complex and vary considerably depending on the preparation and conditions. Protein kinase C has been shown to downregulate GLT-1 in C6 glioma cells (Susarla and Robinson, 2008) , whereas other studies have shown that GLT-1 and GLAST are upregulated by growth factor-induced tyrosine kinase activation and that this effect can be blocked by the tyrosine kinase inhibitors (Zelenaia et al., 2000; Koeberle and Bähr, 2008) . Ouabain has been shown to induce intracellular calcium oscillations via a direct interaction between the N-terminal tail of Na,K-ATPase and the inositol 1,4,5-trisphosphate-ligand binding domain of the IP 3 receptor (Mikoshiba, 2007) , and low concentrations of ouabain can trigger slow, low-frequency calcium oscillations that activate the transcription factor nuclear factor B. It is possible that PKC or other calciumsensitive kinases may be stimulated by ouabain acting on Na,KATPase, which then affects glutamate transporter function.
Pertinent to the issue of linking Na,K-ATPases to glutamate transporters is the consistent finding that ouabain elicits activation of Src tyrosine kinases (Xie, 2003) , which subsequently induces recruitment and phosphorylation of the extracellular signal-regulated kinase ERK (Pierre et al., 2008) . We demonstrate here for the first time that inhibitors of Src reduce glutamate transporter activity. Moreover, the level of glutamate transporter inhibition in synaptosomes was similar to that produced by ouabain, and inhibition after coapplication of Src inhibitors together with ouabain was not different from ouabain alone. Interestingly, Na,K-ATPase is known to form a complex with Src, and this signaling complex or "signalosome" operates independently of the ion transporting functions of the Na,K-ATPase (Xie, 2003; Liang et al., 2007) . In addition, ouabain activation of Src occurs over a broad concentration range (Liang et al., 2007; Pierre et al., 2008) similar to what we observed with glutamate transporter function in synaptosomes. Based on these observations, we speculate that the inhibitory effect of ouabain on glutamate transporters could involve the participation of Src in an Na,K-ATPase/Src/ glutamate transporter protein complex. The finding that Src inhibitors produce the same inhibitory effect as ouabain on glutamate uptake suggests that the effect occurs independently of the phosphorylation function of Src and that Src, possibly via its Src homology 2/3 domains, may be acting more as an adaptor protein (Boggon and Eck, 2004; Pawson, 2004) , linking ouabaininduced conformational changes in Na,K-ATPase to modulation of glutamate transporter activity. Additional studies are required to address this idea.
Collectively, our data demonstrate that the glutamate transporters and Na,K-ATPases are present in the same macromolec- ular complexes and that transporter activity is regulated by the sodium/potassium pump. Our findings prompt an obvious question: how does this multiprotein complex operate from a mechanistic standpoint? Although this question cannot currently be answered, we can speculate based on the functional and structural information presently available, including the crystal structures of the pig Na,K-ATPase (Morth et al., 2007) and a bacterial glutamate transporter with 37% homology to mammalian GLT-1 (Yernool et al., 2004) (Fig. 9A) . Both proteins are thought to undergo conformational changes during activation, and both possess binding sites for sodium and potassium ions (Sweadner and Donnet, 2001; Kanner, 2006) . A direct interaction between the proteins could promote mutually and optimally coordinated conformational shifts such that movement of the transmembrane segments of the sodium/potassium pump may facilitate glutamate transporter activity. We also note that a direct proteinprotein interaction and the participation of other signaling proteins, such as Src, are not mutually exclusive. In astrocytes (and possibly in neurons in which other combinations of neuronally expressed glutamate transporters and Na,K-ATPase subunits are present), glutamate transporters may exist as part of the Na,KATPase/Src signalosome complex in which Src plays a regulatory role in glutamate transporter function.
In the course of these studies, we made the curious observation that, in a variety of cell types including rat forebrain and cerebellar synaptosomes (Fig. 5) , cultured astrocytes (Fig. 6) , and in the human embryonic kidney HEK-293T and Chinese hamster ovary cell lines (data not shown), typically approximately one-third to a maximum of approximately one-half of sodium-dependent glutamate uptake is susceptible to inhibition by ouabain, whereas the remaining one-half to twothirds is impervious to inhibition by ouabain. The consistency of this ratio across species and cell types suggests that some fundamental aspect of protein structure and function may be at play. A widely held view based on the crystal structure of the bacterial glutamate transporter, protein cross-linking experiments on mammalian transporters, fluorescence resonance energy transfer experiments, and other studies is that glutamate transporters are homo-trimers (Gendreau et al., 2004; Yernool et al., 2004) . Intriguingly, additional evidence indicates that the individual protomers within a trimer appear to function independently of one another (Grewer et al., 2005; Koch et al., 2007) .
Based on these findings, together with the results presented here, we propose an arrangement whereby one protomer within the trimer is associated with a molecule of Na,K-ATPase and is therefore inhibitable by ouabain, whereas the other two protomers are not in direct association with the Na,K-ATPase and therefore are not affected by, or are much less susceptible to, ouabain inhibition (Fig. 9B) . Such an arrangement would not only account for the consistently observed ϳ1:2 ratio of ouabain-inhibited/ouabain-resistant glutamate transport but would also imply that a portion of glutamate uptake in the brain is acutely regulated by the status of ATPases, whereas the remaining larger portion may operate in a mode that is independent of the acute status of the Na,K-ATPase. The portion of glutamate transporter activity under direct control of ATPase via the protein-protein interaction may play a role as a fast synaptic activity or energy sensor, whereas activity of the ouabain-resistant fraction may depend indirectly on ATPase function by relying on ion gradients. Although this model is currently hypothetical, future studies will attempt to test these ideas. . Structural and functional aspects of glutamate transporter and Na,K-ATPase interactions. A, Depictions of the crystal structures of the pig Na,K-ATPase and a glutamate transporter from Pyrococcus horikoshii (graphics taken from Morth et al., 2007 and Yernool et al., 2004, respectively) . B, Hypothetical model of the juxtaposition of glutamate (Glu) transporters with Na,KATPase in which only one of the subunits within the trimeric structure of the transporter is associated with Na,K-ATPase.
